Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Herpes simplex Infection

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 10 articles: HTML format

Single Articles

May 2008
1. NAGANO S , Perentes JY, Jain RK, Boucher Y, et al
   Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors.
   Cancer Res. 2008;68:3795-802.
   PubMed     Related articles    Abstract available
   
   
   October 2007
2. YI KH , Nechushtan H, Bowers WJ, Walker GR, et al
   Adoptively Transferred Tumor-Specific T Cells Stimulated Ex vivo Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity In vivo.
   Cancer Res. 2007;67:10027-37.
   PubMed     Related articles    Abstract available
   
   
   
3. VARGHESE S , Rabkin SD, Nielsen GP, Macgarvey U, et al
   Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
   Cancer Res. 2007;67:9371-9.
   PubMed     Related articles    Abstract available
   
   
   September 2007
4. VEERAPONG J , Bickenbach KA, Shao MY, Smith KD, et al
   Systemic Delivery of {gamma}134.5-Deleted Herpes Simplex Virus-1 Selectively Targets and Treats Distant Human Xenograft Tumors That Express High MEK Activity.
   Cancer Res. 2007;67:8301-6.
   PubMed     Related articles    Abstract available
   
   
   August 2007
5. LI H , Zeng Z, Fu X, Zhang X, et al
   Coadministration of a herpes simplex virus-2 based oncolytic virus and cyclophosphamide produces a synergistic antitumor effect and enhances tumor-specific immune responses.
   Cancer Res. 2007;67:7850-5.
   PubMed     Related articles    Abstract available
   
   
   April 2007
6. KURUPPU D , Brownell AL, Zhu A, Yu M, et al
   Positron emission tomography of herpes simplex virus 1 oncolysis.
   Cancer Res. 2007;67:3295-300.
   PubMed     Related articles    Abstract available
   
   
   January 2007
7. AGHI M , Rabkin SD, Martuza RL
   Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
   Cancer Res. 2007;67:440-4.
   PubMed     Related articles    Abstract available
   
   
   October 2006
8. KURODA T , Rabkin SD, Martuza RL
   Effective Treatment of Tumors with Strong {beta}-Catenin/T-Cell Factor Activity by Transcriptionally Targeted Oncolytic Herpes Simplex Virus Vector.
   Cancer Res. 2006;66:10127-35.
   PubMed     Related articles    Abstract available
   
   
   May 2006
9. SIMPSON GR , Han Z, Liu B, Wang Y, et al
   Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control.
   Cancer Res. 2006;66:4835-42.
   PubMed     Related articles    Abstract available
   
   
   April 2006
10. GENTRY BG , Boucher PD, Shewach DS
    Hydroxyurea induces bystander cytotoxicity in cocultures of herpes simplex virus thymidine kinase-expressing and nonexpressing HeLa cells incubated with ganciclovir.
    Cancer Res. 2006;66:3845-51.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: